Development of Novel VEGFR2 Inhibitors Originating from Natural Product Analogues with Antiangiogenic Impact.

MLA

Sung Min Cho, et al. “Development of Novel VEGFR2 Inhibitors Originating from Natural Product Analogues with Antiangiogenic Impact.” Journal of Medicinal Chemistry, vol. 64, no. 21, Nov. 2021, pp. 15858–67. EBSCOhost, https://doi.org/10.1021/acs.jmedchem.1c01168.

APA

Sung Min Cho, Yonghyo Kim, Yooju Jung, Minjeong Ko, Marko-Varga, G., & Ho Jeong Kwon. (2021). Development of Novel VEGFR2 Inhibitors Originating from Natural Product Analogues with Antiangiogenic Impact. Journal of Medicinal Chemistry, 64(21), 15858–15867. https://doi.org/10.1021/acs.jmedchem.1c01168

Chicago

Sung Min Cho, Yonghyo Kim, Yooju Jung, Minjeong Ko, Gyorgy Marko-Varga, and Ho Jeong Kwon. 2021. “Development of Novel VEGFR2 Inhibitors Originating from Natural Product Analogues with Antiangiogenic Impact.” Journal of Medicinal Chemistry 64 (21): 15858–67. doi:10.1021/acs.jmedchem.1c01168.